Business Context and Reporting Period
Company: DaVita Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 3, 2004
Reporting Period: Quarter and nine months ended September 30, 2004.
Context: This filing serves to announce financial results previously released in a press release on November 2, 2004, which is attached as Exhibit 99.1.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The filing explicitly states that these figures are contained within the attached press release (Exhibit 99.1).
The company utilizes the following non-GAAP financial measures to supplement GAAP results:
- Net income excluding Medicare lab recoveries associated with prior years' services.
- Free cash flow.
- Operating cash flows and free cash flows excluding Medicare lab recoveries and tax benefits from stock option exercises.
- Operating income excluding Medicare lab recoveries, depreciation, amortization, and minority interest (used for debt leverage ratio calculations).
- Revenue excluding Medicare lab recoveries.
Material Changes
The filing text does not provide specific data regarding material changes versus prior comparable periods. It notes that the company historically reports non-GAAP measures to exclude non-recurring expenses and Medicare lab recoveries to ensure consistency and comparability, as these items can cause unusual fluctuations in operating performance.
Guidance, Outlook, and Risks
Forward-Looking Statements: The attached press release contains forward-looking statements regarding performance for 2004 and 2005.
Risks and Uncertainties: Actual results may differ materially from forward-looking statements due to known and unknown risks. Investors are directed to review the Annual Report on Form 10-K for the fiscal year ended December 31, 2003, and Quarterly Reports on Form 10-Q for the quarters ending March 31, 2004, and June 30, 2004, for detailed risk factors.
Unusual Items: The company identifies Medicare lab recoveries for prior period services as items that result in unusual fluctuations in operating performance, justifying their exclusion in non-GAAP measures.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated November 2, 2004) for specific GAAP and non-GAAP financial figures.
- Verify the reconciliation of non-GAAP measures to GAAP measures provided in the press release.
- Examine the Form 10-K (2003) and Form 10-Q (2004) filings for detailed risk factors affecting 2004 and 2005 outlooks.
- Confirm the impact of Medicare lab recoveries on reported revenue and net income.